Charles River Laboratories International (CRL) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CRL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To KnowAugust 12, 2025 | msn.comCRL Q2 Deep Dive: Flat Sales and Margin Pressures Offset by Demand Stabilization and Raised OutlookAugust 12, 2025 | finance.yahoo.comCharles River (CRL) Q2 EPS Jumps 11%August 11, 2025 | theglobeandmail.comCharles River raises profit forecast on growing demand for drug development servicesAugust 6, 2025 | msn.comCharles River profit forecast clouded by order cancellations from biotechsAugust 6, 2025 | reuters.comCharles River Laboratories (NYSE:CRL) Delivers Impressive Q2August 6, 2025 | finance.yahoo.comCharles River and BioTech Social Inc. Pursue Crowdfunding PartnershipJuly 31, 2025 | finance.yahoo.comHere's What to Expect From Charles River Laboratories' Next Earnings ReportJuly 18, 2025 | msn.comCharles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference CallJuly 15, 2025 | finance.yahoo.comCharles River Laboratories International (CRL) is Expected to Gain as Industry Growth ResumesJuly 15, 2025 | msn.comCharles River Laboratories: FDA Regulation And High Debt Are Signs Of HeadwindsJuly 2, 2025 | seekingalpha.comIs Charles River Laboratories Stock Underperforming the S&P 500?June 25, 2025 | msn.comCharles River Laboratories International Inc. stock underperforms Monday when compared to competitors despite daily gainsJune 17, 2025 | marketwatch.comDrug Development Inputs & Services Stocks Q1 Results: Benchmarking Charles River Laboratories (NYSE:CRL)May 20, 2025 | msn.comCharles River Laboratories International Inc. stock rises Monday, still underperforms marketMay 12, 2025 | marketwatch.comWhy Are Charles River Laboratories (CRL) Shares Soaring TodayMay 7, 2025 | finance.yahoo.comCharles river raises 2025 guidance with focus on NAMs and cost optimizationMay 7, 2025 | msn.comCharles River surges after Q1 beat, guidance raiseMay 7, 2025 | msn.comCharles River Laboratories’s (NYSE:CRL) Q1: Strong Sales, Stock Jumps 22.4%May 7, 2025 | finance.yahoo.comCharles River Laboratories International Inc. stock rises Friday, still underperforms marketMay 2, 2025 | marketwatch.comCharles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025April 17, 2025 | msn.comFDA ‘surprise’ proposal adds uncertainty for Charles River, says Morgan StanleyApril 11, 2025 | markets.businessinsider.comCharles River Faces Significant Regulatory And Macro PressuresApril 11, 2025 | seekingalpha.comCharles River Labs Stock (CRL) Crashes 28% as FDA Signals End of Animal Testing EraApril 11, 2025 | markets.businessinsider.comFDA’s Intent To Phase Out Animal Testing Requirement Weighs Down Charles River Stock: Retail’s DisheartenedApril 11, 2025 | msn.comCharles River price target lowered to $145 from $160 at BarclaysApril 10, 2025 | markets.businessinsider.comBarclays Sticks to Their Hold Rating for Charles River Labs (CRL)April 10, 2025 | markets.businessinsider.com5CRL : Demystifying Charles River: Insights From 10 Analyst ReviewsMarch 21, 2025 | benzinga.comGoldman Sachs Downgrades Charles River Laboratories International (CRL)March 21, 2025 | msn.comBell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To EarningsFebruary 28, 2025 | msn.comFibroBiologics and Charles River complete master cell bank for clinical trialsFebruary 27, 2025 | markets.businessinsider.comCharles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish?February 26, 2025 | msn.comCharles River Laboratories International's (NYSE:CRL) Soft Earnings Don't Show The Whole PictureFebruary 26, 2025 | finance.yahoo.comCharles River Labs (CRL) Gets a Hold from Evercore ISIFebruary 25, 2025 | markets.businessinsider.comCharles River price target lowered to $179 from $182 at TD CowenFebruary 24, 2025 | markets.businessinsider.comCharles River Laboratories International Full Year 2024 Earnings: EPS Misses ExpectationsFebruary 21, 2025 | finance.yahoo.comJ.P. Morgan Sticks to Their Hold Rating for Charles River Labs (CRL)February 20, 2025 | markets.businessinsider.comCharles River price target lowered to $173 from $177 at BairdFebruary 20, 2025 | markets.businessinsider.comCharles River price target lowered to $160 from $166 at BarclaysFebruary 20, 2025 | markets.businessinsider.comCharles River Laboratories International, Inc. (NYSE:CRL) Q4 2024 Earnings Call TranscriptFebruary 20, 2025 | msn.comCharles River price target lowered to $175 from $195 at Evercore ISIFebruary 20, 2025 | markets.businessinsider.comCharles River Labs diversifies monkey business in face of political headwindsFebruary 20, 2025 | bizjournals.comCharles River Laboratories International Inc (CRL) Q4 2024 Earnings Call Highlights: Navigating ...February 20, 2025 | finance.yahoo.comCharles River Laboratories (NYSE:CRL) Posts Better-Than-Expected Sales In Q4February 19, 2025 | finance.yahoo.comCharles River price target lowered to $166 from $205 at BarclaysFebruary 18, 2025 | markets.businessinsider.comConduit partners with Charles River to evaluate AZD1656February 13, 2025 | markets.businessinsider.comCharles River Laboratories credit outlook lowered to stable at S&P on weak 2025 guidanceJanuary 29, 2025 | msn.comCharles River Laboratories stock hits 52-week low at $160.73January 29, 2025 | msn.comCharles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference CallJanuary 28, 2025 | finance.yahoo.comCharles River price target lowered to $195 from $210 at BofAJanuary 27, 2025 | markets.businessinsider.com Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼0.001.03▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼01▲CRL Articles Average Week Get the Latest News and Ratings for CRL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Trulieve Cannabis News Today Waste Connections News Today Cameco News Today CGI News Today RB Global News Today Stantec News Today MEG Energy News Today Quebecor News Today Stella-Jones News Today Quebecor News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CNSX:CRL) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access